Northwest Biotherapeutics, Inc. (NWBO)
0.1696
0.00 (0.00%)
USD |
OTCM |
Sep 04, 16:00
Northwest Biotherapeutics Debt to Equity Ratio : -1.818 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.818 |
| March 31, 2026 | -1.685 |
| December 31, 2025 | -1.541 |
| September 30, 2025 | -0.8096 |
| June 30, 2025 | -0.8065 |
| March 31, 2025 | -0.8141 |
| December 31, 2024 | -0.8547 |
| September 30, 2024 | -0.9092 |
| June 30, 2024 | -0.9637 |
| March 31, 2024 | -0.9192 |
| December 31, 2023 | -0.9699 |
| September 30, 2023 | -1.002 |
| June 30, 2023 | -0.8647 |
| March 31, 2023 | -0.9756 |
| December 31, 2022 | -0.2501 |
| September 30, 2022 | -0.3218 |
| June 30, 2022 | -0.3423 |
| March 31, 2022 | -0.2791 |
| December 31, 2021 | -0.3062 |
| September 30, 2021 | -0.0862 |
| June 30, 2021 | -0.0738 |
| March 31, 2021 | -0.0702 |
| December 31, 2020 | -0.0547 |
| September 30, 2020 | -0.1119 |
| June 30, 2020 | -0.2564 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.4921 |
| December 31, 2019 | -0.4003 |
| September 30, 2019 | -0.3402 |
| June 30, 2019 | -0.3986 |
| March 31, 2019 | -0.3944 |
| September 30, 2018 | -0.6763 |
| June 30, 2018 | -0.5141 |
| March 31, 2018 | -0.5043 |
| December 31, 2017 | -0.6646 |
| September 30, 2017 | -0.6304 |
| June 30, 2017 | -0.9087 |
| March 31, 2017 | -0.9147 |
| December 31, 2016 | -1.197 |
| September 30, 2016 | -4.199 |
| June 30, 2016 | -1.167 |
| March 31, 2016 | -3.662 |
| December 31, 2015 | -4.847 |
| September 30, 2015 | -0.3971 |
| June 30, 2015 | -0.3268 |
| March 31, 2015 | -0.4267 |
| December 31, 2014 | -0.7326 |
| September 30, 2014 | -0.5981 |
| June 30, 2014 | -0.0394 |
| March 31, 2014 | -0.0377 |
| December 31, 2013 | -0.1245 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 76.02M |
| Total Liabilities (Quarterly) | 110.72M |
| Shareholders Equity (Quarterly) | -34.70M |
| Current Ratio | 0.0351 |
| Net Debt Paydown Yield | 0.38% |